"The discussion highlights the potential of $SCC, drawing comparisons to Biovica's tests, which are perceived as more affordable, suggesting that $SCC may have untapped value. However, there is a sentiment of frustration regarding the lack of attention and discourse surrounding the stock, indicating a concern about its visibility in the market."